Multiplexed cytokine detection on plasmonic gold substrates with enhanced near-infrared fluorescence

Nano Research

Volumn 6, Issue 2, 2013, Pages 113-120

  Zhang, Bo ^a   Price, Jordan ^b   Hong, Guosong ^a   Tabakman, Scott M ^a   Wang, Hailiang ^a   Jarrell, Justin A ^b   Feng, Ju ^a   Utz, Paul J ^b   Dai, Hongjie ^a  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cytokine; microarray; multiplex; near infrared fluorescence; plasmonic

Indexed keywords

EID: 84874189585     PISSN: 19980124     EISSN: 19980000     Source Type: Journal    
DOI: 10.1007/s12274-012-0286-2     Document Type: Article

References (34)

1. Oppenheim, J. J.; Rossio, J. L.; Gearing, A. J. H. Clinical Applications of Cytokines: Role in Pathogenesis, Diagnosis, and Therapy; Oxford University Press: New York, 1993.
2. Lequin, R. M. Enzyme immunoassay (EIA)/enzyme-linked immunosorbent assay (ELISA). Clin. Chem. 2005, 51, 2415-2418.
3. Diaz-Mitoma, F.; Kumar, A.; Karimi, S.; Kryworuchko, M.; Daftarian, M. P.; Creery, W. D.; Filion, L. G.; Cameron, W. Expression of IL-10, IL-4 and interferon-gamma in unstimulated and mitogen-stimulated peripheral blood lymphocytes from HIV-seropositive patients. Clin. Exp. Immunol. 1995, 102, 31-39.
4. de Jager, W.; te Velthuis, H.; Prakken, B. J.; Kuis, W.; Rijkers, G. T. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin. Vaccine Immunol. 2003, 10, 133-139.
5. Khan, S. S.; Smith, M. S.; Reda, D.; Suffredini, A. F.; McCoy, J. P. Jr. Multiplex bead array assays for detection of soluble cytokines: Comparisons of sensitivity and quantitative values among kits from multiple manufacturers. Cytom. Part B: Clin. Cytom. 2004, 61B, 35-39.
6. Dossus, L.; Becker, S.; Achaintre, D.; Kaaks, R.; Rinaldi, S. Validity of multiplex-based assays for cytokine measurements in serum and plasma from "non-diseased" subjects: Comparison with ELISA. J. Immunol. Methods. 2009, 350, 125-132.
7. Utz, P. J. Multiplexed assays for identification of biomarkers and surrogate markers in systemic lupus erythematosus. Lupus2004, 13, 304-311.
8. Robinson, W. H.; Utz, P. J.; Steinman, L. Genomic and proteomic analysis of multiple sclerosis: Opinion. Curr. Opin. Immunol. 2003, 15, 660-667.
9. Hueber, W.; Kidd, B. A.; Tomooka, B. H.; Lee, B. J.; Bruce, B.; Fries, J. F.; Sønderstrup, G.; Monach, P.; Drijfhout, J. W.; van Venrooij, W. J. et al. Antigen microarray profiling of autoantibodies in rheumatoid arthritis. Arthritis Rheum. 2005, 52, 2645-2655.
10. Garren, H.; Robinson, W. H.; Krasulová, E.; Havrdová, E.; Nadj, C.; Selmaj, K.; Losy, J.; Nadj, I.; Radue, E. W.; Kidd, B. A. et al. Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis. Ann. Neurol. 2008, 63, 611-620.
11. Bar-Or, A.; Vollmer, T.; Antel, J.; Arnold, D. L.; Bodner, C. A.; Campagnolo, D.; Gianettoni, J.; Jalili, F.; Kachuck, N.; Lapierre, Y. et al. Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1/2 trial. Arch. Neurol. 2007, 64, 1407-1415.
12. MacBeath, G. Protein microarrays and proteomics. Nat. Genet. 2002, 32, 526-532.
13. Madoz-Gúrpide, J.; Wang, H.; Misek, D. E.; Brichory, F.; Hanash, S. M. Protein based microarrays: A tool for probing the proteome of cancer cells and tissues. Proteomics2001, 1, 1279-1287.
14. MacBeath, G.; Schreiber, S. L. Printing proteins as microarrays for high-throughput function determination. Science2000, 289, 1760-1763.
15. Graf, R.; Friedl, P. Detection of immobilized proteins on nitrocellulose membranes using a biotinylation-dependent system. Anal. Biochem. 1999, 273, 291-297.
16. Li, Y. W.; Reichert, W. M. Adapting cDNA microarray format to cytokine detection protein arrays. Langmuir2003, 19, 1557-1566.
17. Zhu, H.; Snyder, M. Protein arrays and microarrays. Curr. Opin. Chem. Biol. 2001, 5, 40-45.
18. Lesaicherre, M. L.; Uttamchandani, M.; Chen, G. Y. J.; Yao, S. Q. Developing site-specific immobilization strategies of peptides in a microarray. Bioorg. Med. Chem. Lett. 2002, 12, 2079-2083.
19. Schweitzer, B.; Roberts, S.; Grimwade, B.; Shao, W. P.; Wang, M. J.; Fu, Q.; Shu, Q. P.; Laroche, I.; Zhou, Z. M.; Tchernev, V. T. et al. Multiplexed protein profiling on microarrays by rolling-circle amplification. Nat. Biotechnol. 2002, 20, 359-365.
20. Tabakman, S. M.; Chen, Z.; Casalongue, H. S.; Wang, H. L.; Dai, H. J. A new approach to solution-phase gold seeding for SERS substrates. Small2011, 7, 499-505.
21. Hong, G. S.; Tabakman, S. M.; Welsher, K.; Wang, H. L.; Wang, X. R.; Dai, H. J. Metal-enhanced fluorescence of carbon nanotubes. J. Am. Chem. Soc. 2010, 132, 15920-15923.
22. Hong, G. S.; Tabakman, S. M.; Welsher, K.; Chen, Z.; Robinson, J. T.; Wang, H. L.; Zhang, B.; Dai, H. J. Nearinfrared-fluorescence-enhanced molecular imaging of live cells on gold substrates. Angew. Chem. Int. Edit. 2011, 50, 4644-4648.
23. Tabakman, S. M.; Lau, L.; Robinson, J. T.; Price, J.; Sherlock, S. P.; Wang, H. L.; Zhang, B.; Chen, Z.; Tangsombatvisit, S.; Jarrell, J. A. et al. Plasmonic substrates for multiplexed protein microarrays with femtomolar sensitivity and broad dynamic range. Nat. Commun. 2011, 2, 466.
24. Hong, G. S.; Wu, J. Z.; Robinson, J. T.; Wang, H. L.; Zhang, B.; Dai, H. J. Three-dimensional imaging of single nanotube molecule endocytosis on plasmonic substrates. Nat. Commun. 2012, 3, 700.
25. Canney, P. A.; Moore, M.; Wilkinson, P. M.; James, R. D. Ovarian cancer antigen CA125: A prospective clinical assessment of its role as a tumour marker. Br. J. Cancer1984, 50, 765-769.
26. Moertel, C. G.; Fleming, T. R.; Macdonald, J. S.; Haller, D. G.; Laurie, J. A.; Tangen, C. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA. 1993, 270, 943-947.
27. Gorelik, E.; Landsittel, D. P.; Marrangoni, A. M.; Modugno, F.; Velikokhatnaya, L.; Winans, M. T.; Bigbee, W. L.; Herberman, R. B.; Lokshin, A. E. Multiplexed immunobeadbased cytokine profiling for early detection of ovarian cancer. Cancer Epidemiol. Biomarkers Prev. 2005, 14, 981-987.
28. Foti, E.; Ferrandina, G.; Martucci, R.; Romanini, M. E.; Benedetti Panici, P.; Testa, U.; Mancuso, S.; Scambia, G. IL-6, M-CSF and IAP cytokines in ovarian cancer: Simultaneous assessment of serum levels. Oncology1999, 57, 211-215.
29. Gadducci, A.; Ferdeghini, M.; Castellani, C.; Annicchiarico, C.; Gagetti, O.; Prontera, C.; Bianchi, R.; Facchini, V. Serum levels of tumor necrosis factor (TNF), soluble receptors for TNF (55- and 75-kDa sTNFr), and soluble CD14 (sCD14) in epithelial ovarian cancer. Gynecol. Oncol. 1995, 58, 184-188.
30. Gadducci, A.; Ferdeghini, M.; Fanucchi, A.; Annicchiarico, C.; Ciampi, B.; Prontera, C.; Genazzani, A. R. Serum preoperative vascular endothelial growth factor (VEGF) in epithelial ovarian cancer: Relationship with prognostic variables and clinical outcome. Anticancer Res. 1999, 19, 1401-1405.
31. Penson, R. T.; Kronish, K.; Duan, Z.; Feller, A. J.; Stark, P.; Cook, S. E.; Duska, L. R.; Fuller, A. F.; Goodman, A. K.; Nikrui, N. et al. Cytokines IL-1β, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFα in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel. Int. J. Gynecol. Cancer2000, 10, 33-41.
32. Nilsson, M. B.; Langley, R. R.; Fidler, I. J. Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine. Cancer Res. 2005, 65, 10794-10800.
33. Bast, R. C. Jr. Status of tumor markers in ovarian cancer screening. J. Clin. Oncol. 2003, 21, 200s-205s.
34. Gorelik, E.; Landsittel, D. P.; Marrangoni, A. M.; Modugno, F.; Velikokhatnaya, L.; Winans, M. T.; Bigbee, W. L.; Herberman, R. B.; Lokshin, A. E. Multiplexed immunobeadbased cytokine profiling for early detection of ovarian cancer. Cancer Epidemiol. Biomarkers prev. 2005, 14, 981-987.